Close

Analyst Ratings for Marrone Bio Innovations (MBII) [Neutrals]

MBII Rating Summary

  |   Expand Research on MBII
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 6.3 / 10   Percentile Rank: 67%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
3/17/2022 Canaccord Genuity Bobby Burleson Downgrade Hold
(Buy)
1.30
(N/A)
0.70
(0.80)
14.29% Details
8/8/2014 Piper Sandler
» Updated 5/13/2016
N/A Downgrade Neutral
(Overweight)
1.00
(2.00)
9.54
(0.80)
-91.61% Details